<?xml version="1.0" encoding="UTF-8"?>
<p>The obvious question is the mechanism by which the inflammation state in the GI tract can contribute to the dopaminergic degeneration in different circumstances and different PD patients. Those mechanisms may involve:
 <list list-type="simple" id="list0005">
  <list-item id="listitem0005">
   <label>1)</label>
   <p>GI accumulation of 
    <italic>α</italic>-syn that retrogradely and slowly is being transported to the CNS,
   </p>
  </list-item>
  <list-item id="listitem0010">
   <label>1</label>
   <p>Parallel, but similar processes that simultaneously affect central and peripheral dopaminergic neurons,</p>
  </list-item>
  <list-item id="listitem0015">
   <label>2)</label>
   <p>Peripheral inflammation, due to chronically inflamed gut, may trigger 
    <italic>α</italic>-syn deposition, increase the permeability of the gut and the BBB leading to neuroinflammation,
   </p>
  </list-item>
  <list-item id="listitem0020">
   <label>3)</label>
   <p>Inadequate signaling and metabolites from the gut microbiome may occur in addition to the dysregulation of the gut-brain dopaminergic crosstalk.</p>
  </list-item>
 </list>
</p>
